Cancer Research Cell Death Mechanisms and Cancer Therapy  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 39, 3058-3064, August 1, 1979]
© 1979 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Winkelhake, J. L.
Right arrow Articles by Hodach, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Winkelhake, J. L.
Right arrow Articles by Hodach, A.

Immunological Block to Synthetic {alpha}-Melanocyte-stimulating Hormone: Melanocyte Interaction by Antibodies Isolated from Cell-Column Immunoadsorbents1

Jeffrey L. Winkelhake, Barbara M. Elcombe and Albertina Hodach

Departments of Microbiology [J. L. W., B. M. E., A. E. H.] and Pediatrics [A. E. H.], The Medical College of Wisconsin, Milwaukee, Wisconsin 53226 The Medical College of Wisconsin, Milwaukee, Wisconsin 53226

Antibodies to formalin-fixed, syngeneic melanoma cells were prepared in mice, purified by immunoaffinity chromatography, and tested for binding activity to viable melanoma cells. The radiolabeled antibodies detected ~=9 x 106 melanoma antigenic sites/cell. The calculated average association constant (Ka) for the antibody population was 7 to 10 x 107 M–1. The antibody was shown to block the binding of melanocyte-stimulating hormone in competitive cell surface binding studies. Results are discussed conceptually in terms of the potentially important role that the humoral immune response may play in the phenomenon of tumor progression.

1 This work was supported by grants from The Jane Coffin Childs Memorial Fund for Medical Research and the National Science Foundation.

Received 2/20/79. Accepted 4/27/79.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1979 by the American Association for Cancer Research.